As of Jul 22
| -0.89 / -1.33%|
The 1 analysts offering 12-month price forecasts for Cantel Medical Corp have a median target of 65.00, with a high estimate of 65.00 and a low estimate of 65.00. The median estimate represents a -1.41% decrease from the last price of 65.93.
The current consensus among 1 polled investment analysts is to Hold stock in Cantel Medical Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.